Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
NCT07527143 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2026-04-14
Summary
This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.
Conditions
- Endometrial Carcinoma
Interventions
- OTHER
-
Non-Interventional Study
Non-interventional study
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Shariska Harrington, MD · Mayo Clinic in Rochester
Eligibility
- Min Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-04-06
- Primary Completion
- 2027-04-06
- Completion
- 2027-04-06
Countries
- United States
Study Locations
More Related Trials
-
Vaginal Fluid Collection for Detection of Endometrial Cancer
NCT06294886 ·Status: RECRUITING
-
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
NCT04794322 ·Status: RECRUITING
-
Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer
NCT00462969 ·Status: COMPLETED ·Phase: NA
-
Assessment of Screening Modalities for Gynecologic Cancers
NCT00879840 ·Status: COMPLETED
-
Cervical Cytology DNA Methylation for Endometrial Lesion Screening and Follow-up
NCT07298707 ·Status: NOT_YET_RECRUITING
-
DNA Methylation Biomarkers for Cervical Cancer Screening
NCT02605941 ·Status: UNKNOWN
-
Host DNA Methylation for Endometrial Cancer Screening
NCT05290415 ·Status: UNKNOWN
-
Clinical Studies of Endometrial Cytology and Cervical Methylation Assays in Endometrial Cancer Screening and Fertility-Preservation Evaluation
NCT06672341 ·Status: NOT_YET_RECRUITING
-
The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control Study
NCT06846775 ·Status: RECRUITING
-
The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
NCT06283875 ·Status: NOT_YET_RECRUITING
-
Cervical Cancer Screening Project Part C
NCT01575444 ·Status: TERMINATED
-
DNA Cytometry for Cervical Cancer Screening in China
NCT00902551 ·Status: COMPLETED
-
DNA CDO1 and CELF4 Methylation for Endometrial Cancer Screening
NCT05290922 ·Status: UNKNOWN
-
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
NCT04456972 ·Status: COMPLETED ·Phase: NA
-
Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
NCT02441140 ·Status: TERMINATED ·Phase: NA
-
Collecting Tumor Samples From Patients With Gynecological Tumors
NCT00897442 ·Status: COMPLETED
-
Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer
NCT07046936 ·Status: SUSPENDED
-
Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma
NCT05273099 ·Status: UNKNOWN
-
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
NCT01119573 ·Status: UNKNOWN
-
Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fluids
NCT02704650 ·Status: WITHDRAWN ·Phase: NA
-
Methylated Biomarkers Predictive of Endometrial Cancer Risk
NCT06800677 ·Status: ACTIVE_NOT_RECRUITING
-
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
NCT03538665 ·Status: RECRUITING
-
An Observational Study Based on Endometrial Cancer Risk Screening Model
NCT05634798 ·Status: UNKNOWN
-
Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer
NCT07382505 ·Status: NOT_YET_RECRUITING
-
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
NCT00299481 ·Status: UNKNOWN